Standout Papers

Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard ... 2013 2026 2017 2021 383
  1. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy (2013)
    Allen P. Kaplan, Dennis K. Ledford et al. Journal of Allergy and Clinical Immunology

Immediate Impact

53 standout
Sub-graph 1 of 22

Citing Papers

Remibrutinib in Chronic Spontaneous Urticaria
2025 Standout
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
2025 Standout
5 intermediate papers

Works of Joachim Veith being referenced

Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort
2019
Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy
2013 Standout

Author Peers

Author Last Decade Papers Cites
Joachim Veith 62 65 121 439 274 6 630
Nikhil Kamath 55 19 69 370 243 10 523
William Berger 156 6 50 384 235 15 578
Francis 10 2 130 474 330 6 582
Gregory V. Marcotte 26 5 212 181 63 9 602
Abdelkader Rahmaoui 29 1 92 334 189 6 567
Mary S. Bradley 35 1 117 354 192 7 655
Kenneth C. Hertz 25 4 129 301 404 11 714
J Mooney 58 36 88 354 51 11 709
Mark S. Fradin 26 46 302 128 159 10 565
Pearl M. Zeek 153 15 71 282 68 7 640

All Works

Loading papers...

Rankless by CCL
2026